Trends in Securities Class Actions Involving Life Sciences Companies
Bret Leone-Quick discusses the trends that have emerged with respect to the types of claims being asserted in securities class actions against life sciences companies.
Author
Breton Leone-Quick
Member
Breton Leone-Quick is an attorney who advises Mintz clients in the financial services industry in litigation matters and regulatory investigations. He leverages his understanding of federal securities laws and Delaware corporate laws to navigate complex crises and disputes.